Cell cycle arrest and apoptosis induction by Juniperus communis extract in esophageal squamous cell carcinoma through activation of p53‐induced apoptosis …

CY Li, SC Lee, WL Lai, KF Chang… - Food science & …, 2021 - Wiley Online Library
Esophageal squamous cell carcinoma (ESCC) is one of the most common cancers. It has a
high mortality rate and requires novel effective drugs and therapeutic approaches. Juniperus …

Toward targeted therapies in oesophageal cancers: an overview

G Bregni, B Beck - Cancers, 2022 - mdpi.com
Simple Summary Prognosis for patients with oesophageal cancer is poor, because of its
aggressive nature and the lack of targeted therapies. Advances in cancer biology and …

New and emerging combination therapies for esophageal cancer

MW Wiedmann, J Mössner - Cancer management and research, 2013 - Taylor & Francis
Esophageal cancer comprises two different histological forms–squamous cell carcinoma
(SCC) and adenocarcinoma (AC). While the incidence of AC has increased steeply in …

Current targeted therapies in HER2-positive gastric adenocarcinoma

FG Curea, M Hebbar, SM Ilie, XE Bacinschi… - Cancer Biotherapy & …, 2017 - liebertpub.com
Gastric cancer is one of the most common types of cancer in the world, usually diagnosed at
an advanced stage. Despite the advances in specific anticancer agents' development, the …

Expression and prognostic significance of human epidermal growth factor receptors 1 and 3 in gastric and esophageal adenocarcinoma

C Hedner, D Borg, B Nodin, E Karnevi, K Jirström… - PloS one, 2016 - journals.plos.org
Background Gastric and esophageal adenocarcinomas are major global cancer burdens.
These cancer forms are characterized by a poor prognosis and a modest response to chemo …

Controlling angiogenesis in gastric cancer: A systematic review of anti-angiogenic trials

F Shan, R Miao, K Xue, Z Li, Z Li, Z Bu, A Wu, L Zhang… - Cancer Letters, 2016 - Elsevier
Purpose Angiogenesis is a promising therapeutic target to inhibit tumor growth. This review
summarizes data from clinical trials of anti-angiogenic agents in gastric cancer. Design A …

Targeted therapies in metastatic esophageal cancer: advances over the past decade

A Mohamed, B El-Rayes, FR Khuri, NF Saba - Critical Reviews in Oncology …, 2014 - Elsevier
Esophageal cancer is one of the most aggressive malignancies of the upper aerodigestive
tract. Despite advances in surgical techniques and multi-modality therapies, the 5-year …

[HTML][HTML] Targeted therapy for advanced gastric cancer: A review of current status and future prospects

O Kanat, B O'Neil, S Shahda - World journal of gastrointestinal …, 2015 - ncbi.nlm.nih.gov
In the West in particular, the vast majority of gastric cancer (GC) patients present with
advanced-stage disease. Although combination chemotherapy is still the most important …

Identification of EGFR expression status association with metastatic lymph node density (ND) by expression microarray analysis of advanced gastric cancer

A Ema, M Waraya, K Yamashita, K Kokubo… - Cancer …, 2015 - Wiley Online Library
Metastatic lymph node density (ND) has been reproducibly proven to be a prognostic factor
in gastric cancer. The molecular mechanisms that underlie this aggressiveness are …

[HTML][HTML] Exploring the chemotherapeutic potential of currently used kinase inhibitors: An update

RR Naik, AK Shakya - Frontiers in Pharmacology, 2023 - frontiersin.org
Protein kinases are enzymes that transfer phosphate to protein, resulting in the modification
of the protein. The human genome encodes approximately 538 kinases. Kinases play a role …